Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.
Sci Adv
2026
12
4
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma.
Leukemia
2026
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis.
Eur J Cancer
2026
232
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.
Cancer Res
2026
86
2
367-386
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.
Bone Marrow Transplant
2026
61
1
36-43
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.
Bone Marrow Transplant
2026
61
3
333-340
Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.
Nat Genet
2026
58
1
157-168
Immunotherapy in advanced gastroesophageal cancers: A meta-analysis of sex-based outcomes in overall survival.
Int J Cancer
2026
158
10
2697-2708
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependencies.
Leukemia
2026
40
3
522-539
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers.
Haematologica
2026
111
4
1432-1435